Study guide
24.4 Peri-Implant Disease and Systemic Risk Factors
Overseas Registration Examination ORE
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: ORE Part 1 — Exam Blueprint, Logistics and Strategy
1.1 Structure and Format of ORE Part 1 1.2 The Official Blueprint and Preparing for Practice 1.3 Eligibility, Fees, Attempts and Time Limits
2 Chapter 2: Anatomy of the Head and Neck
2.1 The Trigeminal Nerve and Dental Innervation 2.2 The Facial Nerve and Parotid Region 2.3 The Temporomandibular Joint and Muscles of Mastication 2.4 The Infratemporal Fossa and Spread of Odontogenic Infection
3 Chapter 3: Dental Anatomy, Morphology and Occlusion
3.1 Permanent and Primary Tooth Morphology 3.2 Functional Occlusion: Centric Relation, Guidance and Interferences 3.3 Classifying Occlusion: Angle and BSI Incisor Relationships
4 Chapter 4: Genetics, Embryology and Odontogenesis
4.1 Stages of Odontogenesis and Molecular Signalling 4.2 Amelogenesis and Enamel Microstructure 4.3 Dentinogenesis and the Pulp-Dentine Complex 4.4 Cementum, the Periodontal Ligament and Oral Mucosa 4.5 Genetic and Developmental Dental Anomalies
5 Chapter 5: Oral Biology and Salivary Physiology
5.1 Salivary Gland Anatomy, Microarchitecture and Innervation 5.2 Salivary Secretion, Flow Rates and Autonomic Control 5.3 Salivary Buffering Systems and Protective Macromolecules 5.4 Physiology of Mastication and Deglutition 5.5 Taste, Lingual Papillae and Gustatory Pathways 5.6 Xerostomia, Sjogren's Syndrome and Salivary Diagnostics
6 Chapter 6: Physiology of the Major Body Systems
6.1 Cardiovascular and Respiratory Physiology 6.2 Renal, Endocrine and Gastrointestinal Physiology 6.3 Haematology and Haemostasis 6.4 Neurophysiology, Pain and the Autonomic Nervous System
7 Chapter 7: Bone Biology, Calcium Homeostasis and Healing
7.1 Microstructure and Architecture of Alveolar Bone 7.2 Bone Remodelling and the RANK/RANKL/OPG Axis 7.3 Endocrine Control of Calcium and Phosphate 7.4 Extraction Socket Healing and Ridge Resorption 7.5 Impaired Healing: MRONJ, Osteoradionecrosis and Systemic Risk
8 Chapter 8: Oral Microbiology and Biofilm Ecology
8.1 The Oral Microbiome and Biofilm Development 8.2 Cariogenic Microbiology: Mutans Streptococci and Lactobacilli 8.3 Ecological Hypotheses of Dental Caries 8.4 Biofilm Tolerance and the Case for Mechanical Plaque Control
9 Chapter 9: Immunology Relevant to Oral Disease
9.1 Innate Mucosal Immunity and Gingival Crevicular Fluid 9.2 Cellular Immunity in the Periodontium 9.3 Microbial Pathogenesis: Complexes and Keystone Pathogens 9.4 Host-Mediated Tissue Destruction 9.5 Hypersensitivity Reactions in Dental Practice 9.6 Autoimmune Mucocutaneous Bullous Disease 9.7 Immunodeficiency and Oral HIV Manifestations
10 Chapter 10: General Pathology and Neoplasia
10.1 Cellular Adaptation and Mechanisms of Cell Death 10.2 Inflammation, Wound Healing and Repair 10.3 Principles of Neoplasia and Carcinogenesis 10.4 TNM Staging of Oral Cavity Carcinoma
11 Chapter 11: Statistics and Research Methods
11.1 Study Designs and the Hierarchy of Evidence 11.2 Descriptive and Inferential Statistics 11.3 Diagnostic Test Performance 11.4 Critical Appraisal, Bias and Research Governance
12 Chapter 12: Human Disease: Cardiovascular and Respiratory
12.1 Infective Endocarditis and NICE CG64 12.2 Hypertension and Blood Pressure Thresholds for Dental Care 12.3 Angina, Myocardial Infarction and Antiplatelet Therapy 12.4 Asthma, COPD and Respiratory Emergencies
13 Chapter 13: Human Disease: Endocrine, Haematological and Renal
13.1 Diabetes Mellitus and the Periodontal Axis 13.2 Congenital Bleeding and Clotting Disorders 13.3 Anticoagulants and Antiplatelets: The SDCEP Protocol 13.4 Chronic Kidney Disease and Haemodialysis
14 Chapter 14: Human Disease: Gastrointestinal, Hepatic and Neurological
14.1 Gastrointestinal Disease and Intrinsic Dental Erosion 14.2 Liver Disease, Coagulopathy and Viral Hepatitis 14.3 Epilepsy, Stroke and Transient Ischaemic Attack 14.4 Trigeminal Neuralgia, Bell's Palsy and Giant Cell Arteritis
15 Chapter 15: Oral Aspects of Human Disease
15.1 Oral Manifestations of Systemic Disease 15.2 Orofacial Pain and Temporomandibular Disorders 15.3 Dry Mouth, Altered Taste and Halitosis
16 Chapter 16: Infection Prevention and Control
16.1 The Decontamination Cycle, Sterilization and Waterlines 16.2 Routes of Transmission and Blood-Borne Viruses
17 Chapter 17: Dental Materials
17.1 Dental Amalgam: Metallurgy and UK Regulation 17.2 Resin Composites: Chemistry and Placement 17.3 Dental Adhesive Systems 17.4 Acid Etching, the Hybrid Layer and MMP Degradation 17.5 Glass Ionomer Cements, RMGICs and Compomers 17.6 Impression Materials and Digital Scanning 17.7 Luting Cements and Adhesive Conditioning Protocols 17.8 Dental Ceramics and Cast Alloys 17.9 Gypsum Products, Waxes and Denture Base Polymers
18 Chapter 18: Behavioural Sciences Relevant to Oral Health Care
18.1 Health Behaviour Models and Behaviour Change 18.2 Dental Anxiety and Phobia 18.3 Psychosocial and Sociological Determinants of Oral Health
19 Chapter 19: Patient Assessment and Diagnosis
19.1 History Taking and Clinical Examination 19.2 Special Investigations and Reaching a Diagnosis
20 Chapter 20: Treatment Planning and Risk-Based Care
20.1 Treatment Planning and Sequencing 20.2 Risk Assessment, Recall Intervals and Preventive Planning
21 Chapter 21: Cariology and Caries Risk Assessment
21.1 Caries Pathogenesis and the Stephan Curve 21.2 Histopathology of Enamel and Dentinal Caries 21.3 Caries Diagnosis, ICDAS and Risk Assessment
22 Chapter 22: Operative Dentistry and Minimal Intervention
22.1 Minimal Intervention and Selective Caries Removal 22.2 Pulp Vitality Assessment and Biological Pulp Capping 22.3 Cavity Design, the C-Factor and Margin Geometry
23 Chapter 23: Endodontics
23.1 Pulp Histology and the Low-Compliance Environment 23.2 Pulpal Neurophysiology and Dentine Hypersensitivity 23.3 Pulpal and Periapical Diagnostic Terminology 23.4 Endodontic Diagnostic Testing 23.5 Access Cavity Design and Canal Configurations 23.6 Working Length Determination and Canal Preparation 23.7 Chemical Disinfection and Irrigant Activation 23.8 Medicaments, Obturation Materials and Techniques 23.9 Restoring Endodontically Treated Teeth 23.10 Endodontic Emergencies, Cracked Teeth and Root Fracture
24 Chapter 24: Periodontology
24.1 The 2018 Classification and Periodontal Health 24.2 Plaque-Induced and Non-Plaque-Induced Gingival Disease 24.3 Staging and Grading Periodontitis 24.4 Peri-Implant Disease and Systemic Risk Factors 24.5 The Basic Periodontal Examination 24.6 Simplified BPE in Children and Full Periodontal Charting 24.7 Furcation Involvement, Mobility and Occlusal Trauma 24.8 The BSP Stepwise Treatment Framework 24.9 Periodontal Instrumentation and Healing 24.10 Re-Evaluation, Endpoints and Periodontal Surgery 24.11 Crown Lengthening, Supracrestal Attachment and Supportive Care
25 Chapter 25: Fixed Prosthodontics
25.1 Biomechanical Principles of Tooth Preparation 25.2 Margin Design and the Supracrestal Attachment 25.3 Bridge Design and Resin-Bonded Bridges 25.4 Gingival Retraction, Provisionals and Temporary Cements
26 Chapter 26: Removable Prosthodontics
26.1 Removable Partial Dentures: Classification, Design and Surveying 26.2 Complete Dentures: Principles, Impressions and Jaw Registration
27 Chapter 27: Paediatric Dentistry
27.1 Primary Tooth Anatomy and Caries Management Strategies 27.2 Preformed Metal Crowns and the Hall Technique 27.3 Pulp Therapy in Primary Teeth 27.4 Extractions in the Primary Dentition 27.5 Non-Pharmacological Behaviour Management 27.6 Inhalation Sedation in Paediatric Dentistry 27.7 The Developing Dentition and Space Management 27.8 Serial Extraction and Non-Nutritive Sucking Habits
28 Chapter 28: Dental Traumatology
28.1 Trauma Assessment and Fractures of Permanent Teeth 28.2 Luxation Injuries, Avulsion and Replantation 28.3 Primary Tooth Trauma and Splinting Specifications
29 Chapter 29: Orthodontics
29.1 Extraoral Orthodontic Assessment 29.2 Intraoral Occlusal Assessment 29.3 Skeletal Pattern and Cephalometric Analysis 29.4 IOTN and NHS Treatment Eligibility 29.5 Upper Removable Appliances 29.6 Functional and Fixed Appliances 29.7 Biology of Orthodontic Tooth Movement 29.8 Orthodontic Risks and Retention
30 Chapter 30: Oral Surgery
30.1 Exodontia Biomechanics and Instrument Selection 30.2 Surgical Flap Design, Bone Removal and Suturing 30.3 Third Molar Surgery and NICE Guidance 30.4 Dry Socket and Oroantral Communication 30.5 Odontogenic Infection and Fascial Space Spread
31 Chapter 31: Oral Medicine
31.1 Recurrent Aphthous Stomatitis 31.2 Oral Candidiasis 31.3 Viral Oral Infections 31.4 Reactive Soft Tissue Lesions and the Epulides 31.5 Oral Potentially Malignant Disorders 31.6 Oral Squamous Cell Carcinoma, Urgent Referral and Biopsy
32 Chapter 32: Oral Pathology
32.1 Odontogenic and Non-Odontogenic Cysts 32.2 Odontogenic Tumours 32.3 Obstructive and Reactive Salivary Gland Disease 32.4 Salivary Gland Neoplasms
33 Chapter 33: Therapeutics and Prescribing
33.1 Local Anaesthetic Chemistry and Mechanism of Action 33.2 UK Local Anaesthetic Formulations 33.3 Vasoconstrictors, Maximum Doses and Systemic Toxicity 33.4 Analgesics for Acute Dental Pain 33.5 Antimicrobial Stewardship and First-Line Regimens 33.6 Antifungal and Antiviral Therapeutics
34 Chapter 34: Medical Emergencies in Dental Practice
34.1 The ABCDE Approach and the Emergency Drug Kit 34.2 Anaphylaxis and Acute Coronary Syndrome 34.3 Hypoglycaemia, Acute Asthma and Seizures 34.4 Syncope, Adrenal Crisis, Choking and Resuscitation
35 Chapter 35: Dental Radiology and Radiation Protection
35.1 Radiation Physics, Filtration and Collimation 35.2 Intraoral, Bitewing and Occlusal Projections 35.3 Dental Panoramic Tomography: Principles, Positioning and Errors 35.4 Lateral Cephalometry and Cone Beam CT 35.5 Systematic Reporting and Radiographic Caries Diagnosis 35.6 Radiology of Periodontal Bone Loss and Jaw Lesions 35.7 Radiographic Quality Assurance 35.8 IRR17 and IR(ME)R 2017
36 Chapter 36: Special Care Dentistry and Conscious Sedation
36.1 Special Care Dentistry, Risk Stratification and Sedation Principles 36.2 Inhalation Sedation with Nitrous Oxide 36.3 Intravenous Sedation with Midazolam 36.4 Oral Sedation and General Anaesthesia Referral
37 Chapter 37: Dental Public Health
37.1 Delivering Better Oral Health and the Fluoride Toolkit 37.2 Oral Health Epidemiology and Indices 37.3 Inequalities, Water Fluoridation and Population Prevention 37.4 NHS Dental Services, Access and Commissioning
38 Chapter 38: Communication and Interpersonal Skills
38.1 Patient Communication and Shared Decision-Making 38.2 Breaking Bad News, Complaints and the Duty of Candour 38.3 Referrals, Records and Communication with the Team
39 Chapter 39: Consent and Capacity
39.1 Valid Consent and the Montgomery Standard 39.2 The Mental Capacity Act 2005 39.3 Best Interests Decisions and Lasting Power of Attorney 39.4 Consent in Children and Young People 39.5 Safeguarding Children and Vulnerable Adults 39.6 Confidentiality, Data Protection and Lawful Disclosure
40 Chapter 40: Clinical Professionalism and the GDC
40.1 The General Dental Council and Standards Principles 1 to 4 40.2 GDC Standards: Principles 5 to 9 40.3 The GDC Fitness to Practise Process 40.4 Clinical Governance and the Audit Cycle
41 Chapter 41: Health and Safety Law in Dental Practice
41.1 Health and Safety Legislation, COSHH, RIDDOR and Sharps
42 Chapter 42: Self-Management and Professional Development
42.1 Enhanced CPD, Lifelong Learning and Reflective Practice 42.2 Managing Time, Stress and Clinical Wellbeing 42.3 Leadership, Delegation and Practice Management
24.4 Peri-Implant Disease and Systemic Risk Factors
Key Takeaways Explain This Topic AI
Peri-implant mucositis is bleeding or suppuration on probing without progressive bone loss beyond initial remodelling.
Peri-implantitis adds radiographic bone loss, conventionally 3 mm or more apical to the most coronal intra-osseous part of the implant, often with probing depths of 6 mm or more.
Smoking masks gingival inflammation through nicotine-induced vasoconstriction, so bleeding on probing under-reports disease in smokers.
Smoking also suppresses IgG2, impairs fibroblast and osteoblast function and shifts the subgingival flora.
In diabetes the AGE-RAGE axis amplifies NF-kappaB signalling, raising IL-1beta, TNF-alpha, IL-6 and PGE2 and tipping the RANKL to OPG ratio towards bone loss.
Last updated: September 2026
5. Peri-Implant Diseases and Conditions
With dental implants representing a standard restorative modality in the UK, understanding peri-implant pathology is mandatory for the ORE Part 1 examination. Natural Tooth vs Dental Implant Periodontal Architecture
- ┌───────────────────────────────────────────────┬───────────────────────────────────────────────┐
- │ Natural Tooth │ Dental Implant │
- ├───────────────────────────────────────────────┼───────────────────────────────────────────────┤
- │ Sharpey's fibres insert perpendicularly into │ No Sharpey's fibres; collagen fibres run │
- │ root cementum (Physical mechanical barrier). │ parallel / circular to titanium surface. │
- │ Rich vascular supply from PDL, alveolar bone, │ Hypovascular, hypocellular scar-like cuff; │
- │ and supraperiosteal vessels. │ vascular supply derived solely from bone/peri.│
- │ High probing resistance; probe tip stops │ Lower probing resistance; probe tip routinely │
- │ coronal to connective tissue attachment. │ penetrates deeper into connective zone. │
- │ Periodontal ligament space (Physiological │ Direct bone-to-implant contact (Osseointeg- │
- │ mobility, sensory proprioception). │ ration); no PDL, zero physiological mobility. │
- └───────────────────────────────────────────────┴───────────────────────────────────────────────┘
- Diagnostic Criteria for Peri-Implant Pathology
Peri-Implant Health: Absence of clinical signs of erythema, oedema, bleeding on probing, and suppuration. Stable probing depths over time. Absence of progressive marginal bone loss beyond initial physiological bone remodeling following implant placement.
Peri-Implant Mucositis: Biofilm-induced inflammatory lesion confined strictly to the peri-implant mucosal cuff without loss of supporting crestal bone. Manifests as bleeding on gentle probing (BOP) and/or erythema and oedema. Reversible upon effective professional plaque removal.
Peri-Implantitis: A plaque-associated pathological condition occurring in tissues around dental implants, characterized by mucosal inflammation (profuse BOP and/or suppuration), increased probing pocket depths relative to baseline examination, and progressive loss of supporting crestal alveolar bone extending beyond physiological remodelling.
Important
Diagnostic Thresholds in the Absence of Baseline Radiographs / Records: If initial baseline radiographs and probing depths post-reconstruction are unavailable, a definitive diagnosis of Peri-Implantitis is established by:
- Presence of profuse bleeding on probing (BOP) and/or suppuration ; AND
- Probing pocket depths of ≥ 6 mm \ge 6\text{ mm} ≥ 6 mm ; AND
Radiographic crestal bone levels situated ≥ 3 mm \ge 3\text{ mm} ≥ 3 mm apical to the most coronal portion of the intraosseous component of the implant.
- 6. Systemic Risk Factors: Tobacco Smoking and Diabetes Mellitus
- Tobacco Smoking: Cellular and Vascular Pathophysiology
Tobacco smoking is the single most significant environmental risk factor for the development, progression, and treatment failure of periodontitis. It displays a clear dose-response relationship. Tobacco Smoking (Nicotine)
- │
- ┌────────────────────────────────┼────────────────────────────────┐
- ▼ ▼ ▼
- Peripheral Vasoconstriction Immune Dysregulation Tissue Destruction
- Blunts erythema/BOP - Impaired PMN chemotaxis - Suppressed fibroblasts
- Masks clinical signs - Defective phagocytosis - Decreased collagen I
- Gingiva appears pink/fibrotic - Reduced serum IgG2 - Upregulated MMP-8/9
- Anaerobic shift (P.g., T.f.) - Rapid alveolar RBL
Vascular Suppression (The Clinical Masking Effect): Nicotine stimulates peripheral sympathetic ganglia and alpha-1 adrenergic receptors, inducing profound local microvascular vasoconstriction. Consequently, smokers exhibit significantly reduced gingival bleeding on probing, decreased crevicular fluid flow, and pale, fibrotic gingival margins , even in the presence of severe, deep subgingival destructive periodontitis. This clinical masking frequently leads to delayed presentation and underdiagnosis.
Impairment of Host Polymorphonuclear Neutrophils (PMNs): While smokers often exhibit elevated systemic neutrophil counts, these cells display severely compromised chemotactic migration, diminished trans-endothelial diapedesis, and impaired bacterial phagocytosis and oxidative burst killing.
Humoral Immunosuppression: Smokers demonstrate significantly depressed serum concentrations of IgG2 , the primary protective immunoglobulin subclass directed against polysaccharide capsular antigens of periodontal pathogens like Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans .
Microbial Dysbiosis: The reduced local oxidation-reduction potential ( E h Eh E h ) within the subgingival pocket selects for an earlier, more extensive colonisation by virulent anaerobic "red complex" pathogens ( P. gingivalis , Tannerella forsythia , Treponema denticola ).
Fibroblast and Osteoblast Inhibition: Nicotine binds directly to root surfaces, inhibiting periodontal ligament fibroblastic proliferation, spreading, and collagen synthesis, while upregulating host matrix metalloproteinases (MMP-1, MMP-8, MMP-9) and stimulating osteoclastic bone resorption via elevated RANKL expression.
Diabetes Mellitus: The Hyper-Inflammatory Paradigm
Diabetes mellitus exhibits a robust, bi-directional relationship with periodontitis: poorly controlled diabetes accelerates periodontitis severity, while severe active periodontitis impairs systemic glycaemic control. Chronic Hyperglycaemia
- │
- ▼
- Accumulation of Advanced Glycation End-Products (AGEs)
- │
- ▼
- Binding to RAGE on Macrophages, Monocytes & Endothelium
- │
- ▼
- Activation of NF-κB Transcription Signaling Pathway
- │
- ┌──────────────────────────┴──────────────────────────┐
- ▼ ▼
- Hyper-Inflammatory Cytokine Storm Microvascular Alterations
- Massive release of TNF-α, IL-1β, IL-6 - Endothelial basement membrane thickening
- Massive upregulation of RANKL (Overwhelms OPG) - Impaired trans-capillary nutrient exchange
- Uncontrolled osteoclastogenesis & rapid RBL - Compromised leukocyte emigration
The AGE-RAGE Axis: In sustained hyperglycaemia, circulating glucose binds non-enzymatically to collagen, structural proteins, and lipoproteins, forming stable, irreversible Advanced Glycation End-products (AGEs) . AGEs bind with high affinity to the Receptor for AGE (RAGE) expressed abundantly on the membranes of monocytes, macrophages, endothelial cells, and osteoblasts.
The Cytokine Storm: Ligation of RAGE triggers activation of nuclear factor kappa B ( NF-κB ), driving transcription and uncontrolled systemic release of pro-inflammatory cytokines: Tumour Necrosis Factor-alpha (TNF-α) , Interleukin-1 beta (IL-1β) , Interleukin-6 (IL-6) , and Prostaglandin E2 ( P G E 2 PGE_2 PG E 2 ) . Monocytes from diabetic patients adopt a hyper-inflammatory phenotype, producing up to three to four times more inflammatory mediators in response to bacterial lipopolysaccharide (LPS) than non-diabetic controls.
Altered Bone Turnover (RANKL / OPG Ratio): TNF-α and IL-1β markedly upregulate the expression of RANKL (Receptor Activator of Nuclear Factor-κB Ligand) on osteoblasts and T-lymphocytes, while simultaneously suppressing Osteoprotegerin (OPG) , the physiological decoy receptor. The resulting spike in the RANKL/OPG ratio drives uninhibited differentiation, activation, and survival of multinucleated osteoclasts, causing accelerated, extensive alveolar bone resorption.
Microvascular Pathophysiology: Diabetic microangiopathy induces diffuse thickening and cross-linking of the vascular endothelial basement membrane. This impedes trans-capillary oxygen diffusion, nutrient delivery, and metabolic waste removal, while blunting PMN diapedesis into the gingival crevice and stalling wound repair.
The Bi-Directional Impact on Glycaemic Control: Periodontal infection acts as a chronic systemic inflammatory focus. The systemic dissemination of periodontopathic bacteria, endotoxins, and pro-inflammatory mediators (specifically TNF-α and IL-6) into the systemic circulation induces peripheral insulin resistance by downregulating insulin receptor substrate-1 (IRS-1) phosphorylation in skeletal muscle and adipose tissue. High-quality randomised controlled trials demonstrate that successful non-surgical periodontal therapy (Step 1 and Step 2 debridement) yields an average reduction in HbA1c of approximately 0.4 % 0.4\% 0.4% ( 4 mmol/mol 4\text{ mmol/mol} 4 mmol/mol ) at 3 to 4 months—a therapeutic improvement clinically equivalent to adding a second oral hypoglycaemic pharmacotherapy.
7. Clinical Traps, Pitfalls, and Worked Scenarios
Caution
Clinical Trap: The "Pink, Firm Gingiva" in Heavy Smokers: A 46-year-old patient who smokes 20 cigarettes per day attends for a routine examination. Visual inspection reveals pale, coral-pink gingival margins with zero obvious oedema, knife-edged margins, and a bleeding on probing score of only 4%. A novice practitioner might mistake this presentation for clinical periodontal health and record BPE Codes of 0 or 1. However, full-mouth probing reveals generalized probing pocket depths of 6 to 8 mm with extensive interdental attachment loss and radiographic bone loss reaching the apical third of multiple teeth. The local vasoconstrictive and immunosuppressive effects of nicotine have completely suppressed inflammatory erythema and bleeding. Never rely on visual appearance or absence of bleeding in smokers; thorough periodontal probing is non-negotiable.
Warning
Clinical Trap: Confounding Pseudopockets with True Periodontitis: A 52-year-old hypertensive patient taking amlodipine (10 mg daily) presents with generalized 5 to 6 mm probing depths around all teeth. Bitewing radiographs demonstrate pristine alveolar bone levels situated 1 mm apical to the cemento-enamel junction across the entire dentition. Calculating attachment loss reveals that the gingival margin is located 3 mm coronal to the CEJ (gingival overgrowth). True Clinical Attachment Loss (CAL) is zero ( CAL = PPD 6 mm − Overgrowth 3 mm = 0 mm \text{CAL} = \text{PPD } 6\text{ mm} - \text{Overgrowth } 3\text{ mm} = 0\text{ mm} CAL = PPD 6 mm − Overgrowth 3 mm = 0 mm attachment loss at the CEJ). Diagnosing this patient with Stage III periodontitis and performing aggressive subgingival root planing is a diagnostic error. The correct diagnosis is Drug-Induced Gingival Enlargement (DIGE) on an intact periodontium with gingival pseudopocketing.
Worked Clinical SBA Scenario
Scenario: A 48-year-old female presents to your clinic complaining of loose lower front teeth and persistent halitosis. She reports smoking 15 cigarettes per day for 25 years. Clinical examination reveals generalized interdental clinical attachment loss of 5 to 6 mm at multiple teeth. Probing pocket depths range between 5 and 7 mm. Tooth 46 exhibits 6 mm of attachment loss and Grade II furcation involvement. Periapical radiographs demonstrate horizontal and vertical bone loss extending to 48% of the root length at tooth 46. She has lost teeth 16 and 26 due to periodontal mobility three years ago, but retains 26 functional teeth with no secondary occlusal collapse or masticatory dysfunction. Medical history reveals well-controlled asthma, with normal glycaemic indices.
Question: What is the definitive periodontal diagnosis according to the 2018 EFP/AAP Classification as implemented by the British Society of Periodontology?
Clinical Reasoning Formulation:
Case Definition: The patient exhibits interdental CAL ≥ 5 mm \ge 5\text{ mm} ≥ 5 mm at multiple non-adjacent teeth not attributable to trauma or caries. She is a confirmed case of periodontitis.
Staging: The maximum interdental CAL is ≥ 5 mm \ge 5\text{ mm} ≥ 5 mm (worst site 6 mm 6\text{ mm} 6 mm at tooth 46), radiographic bone loss extends into the middle third ( 48 % 48\% 48% , exceeding 33 % 33\% 33% ), there are vertical defects and Class II furcation involvement, and tooth loss due to periodontitis is 2 teeth (which is ≤ 4 teeth \le 4\text{ teeth} ≤ 4 teeth ). Because she retains > 20 > 20 > 20 teeth without bite collapse, secondary occlusal trauma, or flaring, this meets all criteria for Stage III (and has not progressed to Stage IV complexity).
Grading: Calculating indirect evidence via bone loss / age: 48 % RBL 48 years of age = 1.00 \frac{48\%\text{ RBL}}{48\text{ years of age}} = 1.00 48 years of age 48% RBL = 1.00 . A ratio of 1.00 1.00 1.00 sits at the boundary of Grade B/C. However, the patient is a heavy cigarette smoker consuming 15 cigarettes per day ( ≥ 10 cigarettes/day \ge 10\text{ cigarettes/day} ≥ 10 cigarettes/day ). Under the grading framework, smoking ≥ 10 \ge 10 ≥ 10 cigarettes daily is an automatic grade modifier that mandates assignment of Grade C .
Extent: Generalized interdental attachment loss and pocketing affects ≥ 30 % \ge 30\% ≥ 30% of the remaining dentition, classifying the extent as Generalised .
Definitive Diagnosis: Generalised Periodontitis; Stage III, Grade C; currently unstable; active risk factor: cigarette smoking (15/day).